We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cambridge Cognition Holdings Plc | LSE:COG | London | Ordinary Share | GB00B8DV9647 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 48.50 | 48.00 | 49.00 | 49.00 | 48.50 | 48.50 | 56,690 | 08:00:28 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 12.61M | -409k | -0.0117 | -41.45 | 16.9M |
Date | Subject | Author | Discuss |
---|---|---|---|
26/11/2019 10:48 | Looks much better and no stock available or at best very small amounts. | dave4545 | |
25/11/2019 08:46 | I see these back to placing price 72p, coming months on positive rns coming through.When directors buy that's always a great sign. They know the company better than us. | montyhedge | |
28/10/2019 19:47 | When directors bought shares last month, they know the company better than us, very encouraging. Perhaps news coming. Market cap is peanuts.60p easily on one good rns. | montyhedge | |
28/10/2019 17:33 | Friday trade. Looks like it cleared a 151k seller. Dormant stocks always have overhangs that need to clear first. So once the 30p stock is cleared (no idea how much there is) then it will move strongly. And the last chart I saw like this was in PHD and they did fill the gap from 30p to 60p | dave4545 | |
28/10/2019 17:19 | I see someone bought 125,000 at 30p.Directors bought shares last month always a good sign. | montyhedge | |
28/10/2019 17:17 | This is great punt, smart money we're in at the placing at 72p not long ago.So at 29p market cap is peanuts. If say deal with Biogen or other pharma, on early Alzheimer's tests, straight to 125p. | montyhedge | |
28/10/2019 15:00 | Lots of nibbles, stock looks illiquid so when this line of stock at 30p offer gets clear I think it will gap up quickly to 40p | dave4545 | |
28/10/2019 07:55 | Great looking chart, could gap back up quickly on positive sentiment | dave4545 | |
25/10/2019 16:24 | Be interesting to see if the directors buy any more, they bought last month, always like to see that. I notice Nigel Wray has a stake has well. | montyhedge | |
25/10/2019 14:47 | Interesting been running the slide rule over this one, seems hardly anyone knows about this company, looking at the bullentin boards had a placing not long ago at 72p, this rns today seems things could be turning and exciting times ahead. at 29p to buy market cap is peanuts. Director buy last month always a good sign I think. One of those stocks if goes right, could be a 10 bagger, just my view. | montyhedge | |
01/9/2019 11:14 | I think so especially for a new entry down 74% on the year. Fair value around 45p. Few large buys just before close of trade on Friday. 3 x 50000 must be confident. News on a new contract could land at anytime. | barndale99 | |
28/8/2019 09:24 | Drop seems to be Rather harsh, is there an opporunity presenting itself here sub 40p? | momentum1 | |
28/8/2019 07:31 | As I said in the past, this is a typical AIM lifestyle company - there just for the benefit of the board of directors. phowdo - 19 Dec 2018 - 08:07:21 - 66 of 81 Cambridge Cognition Holdings (COG) Warning signs were there... phowdo - 22 Mar 2018 - 10:22:24 - 61 of 66 Cambridge Cognition Holdings (COG) Happy I sold out last year. This is a lifestyle business for directors. The fact they were happy to take options but not risk their own "hard earned" buying shares is telling. | phowdo | |
27/8/2019 17:48 | In his second column, Simon has been wrong footed by this morning's profit warning from Cambridge Cognition, a small-cap company that has developed a suite of computer-based cognitive assessments to improve the understanding, diagnosis and treatment of neurological and psychological diseases. So, too, have analysts who have withdrawn their forecasts ahead of next month’s interim results. Selling is one of the most difficult disciplinE 10p seems right | onjohn | |
27/8/2019 16:27 | next placing at 10p | onjohn | |
27/8/2019 10:51 | Not a pretty sight. Someone took their eye off the ball, or did they just delay telling us. Their problems didn't happen over night. | tratante | |
27/8/2019 10:21 | FinnCap's old forecast was revenue £8.2m with pretax loss of £0.3m for yr to December. Today's revised figures are £5.5m and -£2.8m respectively. I wouldn't been surprised if Simon Thompson dumped COG later today. It's hard to gloss over such a shocking update. | eagle eye | |
27/8/2019 08:24 | Oh look 34p. How did that happen? | minja19 | |
27/8/2019 07:52 | Loss of £2.8m expected Disaster | nobilis | |
27/8/2019 07:40 | Oh dear. I'll go for 34p | minja19 | |
27/8/2019 07:26 | Profit warning Redundancies 46p today? | nobilis | |
14/6/2019 14:45 | Cog has suddenly come to life. Result of the recent capital markets day perhaps. | tratante | |
13/5/2019 11:12 | memantine hydrochloride, whilst not a cure seems a good medication slowing process down, which is just one of drugs available prescribed if MRI scan shows damage, and results in getting above medication can be a slow process over a few months | mike24 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions